The dis-economy of precision medicine: how stratification multiplies social tension in healthcare systems
Open Access
- 11 July 2026
- journal article
- scientific contribution
- Published by Springer Nature in Medicine, Health Care and Philosophy
- Vol. 29 (4) , 923-930
Abstract
Precision medicine (PM) promises better outcomes by aligning prevention and treatment with molecular and phenotypic profiles. But precision is not merely a clinical refinement; it is an epistemic shift in how health systems classify risk, allocate eligibility and define value. In this study, we argue that broad adoption of PM creates structural tension within solidarity-based health systems and exposes limits in conventional cost-effectiveness evaluation. Ethically, PM converts pooled probabilistic uncertainty into individualized biological prediction, making access increasingly conditional on measurement, interpretation and pathway completion. Economically, PM fragments evaluable populations, destabilizes counterfactual comparison and shifts value from discrete products to information-dependent care pathways. As a result, standard metrics such as the incremental cost-effectiveness ratio (ICER) often become sensitive not only to biological effect, but also to governance: who is tested, how results are interpreted, which downstream services are funded and who can complete the pathway. We suggest that the instability observed in PM appraisal is not simply a technical problem of modeling, but a sign that the object of evaluation has changed. Recognizing this structural shift is essential if PM is to be integrated into health systems committed to both equity and evaluability.Keywords
Funding Information
- University of Basel
This publication has 46 references indexed in Scilit:
- Precision medicine and the problem of structural injusticeMedicine, Health Care and Philosophy, 2023
- The Value of Health in a Cost-Effectiveness Analysis: Theory Versus PracticePharmacoEconomics, 2023
- Precision medicine and the fragmentation of solidarity (and justice)Medicine, Health Care and Philosophy, 2022
- Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest GroupValue in Health, 2020
- Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and EuropeClinical Pharmacology & Therapeutics, 2020
- Cost-effectiveness of precision medicine: a scoping reviewInternational Journal of Public Health, 2019
- Personalized Medicine and the Power of Electronic Health RecordsCell, 2019
- Bismarck and the Long Road to Universal Health Coverage2018
- Measuring efficiency of health plan payment systems in managed competition health insurance marketsJournal of Health Economics, 2017
- Spillover effects of supplementary on basic health insurance: evidence from the NetherlandsThe European Journal of Health Economics, 2010